Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

SRx Health Solutions (SRXH) Net Margin (2016 - 2025)

SRx Health Solutions' Net Margin history spans 10 years, with the latest figure at 146.66% for Q2 2025.

  • For Q2 2025, Net Margin fell 14038.0% year-over-year to 146.66%; the TTM value through Sep 2025 reached 57.5%, down 2988.0%, while the annual FY2024 figure was 32.73%, 9173.0% up from the prior year.
  • Net Margin reached 146.66% in Q2 2025 per SRXH's latest filing, down from 13.47% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 225.46% in Q2 2021 to a low of 262.92% in Q4 2022.
  • Average Net Margin over 5 years is 48.86%, with a median of 27.29% recorded in 2022.
  • Peak YoY movement for Net Margin: soared 41094bps in 2021, then crashed -25190bps in 2022.
  • A 5-year view of Net Margin shows it stood at 46.26% in 2021, then plummeted by -468bps to 262.92% in 2022, then increased by 2bps to 257.82% in 2023, then skyrocketed by 92bps to 20.75% in 2024, then tumbled by -607bps to 146.66% in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Net Margin are 146.66% (Q2 2025), 13.47% (Q1 2025), and 20.75% (Q4 2024).